World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
12337
World Ranking
9345
National Ranking
284

Xu Shen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Xu Shen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 264 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Xu Shen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Xu Shen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Xu Shen is affiliated with Nanjing University of Chinese Medicine in China and has an extensive research portfolio primarily focused on medicine and neuroscience. Their scholarly work spans several subfields, including neurology, physiology, molecular biology, organic chemistry, and pharmacology. This multidisciplinary approach supports investigations into neuroinflammation, pain mechanisms, and neurodegenerative diseases.

Their research covers a variety of main topics such as:

  • Neuroinflammation and Neurodegeneration Mechanisms
  • Pain Mechanisms and Treatments
  • Stress Responses and Cortisol
  • Alzheimer's disease research and treatments
  • Tryptophan and brain disorders
  • Pharmacological Effects of Natural Compounds
  • Catalytic C-H Functionalization Methods

Xu Shen's frequent publication venues include:

  • Acta Pharmacologica Sinica
  • Phytomedicine
  • Aging Cell
  • Diabetes
  • Research Square (Research Square)

Their recent papers demonstrate a research focus on brain disorders, molecular pharmacology, and therapeutic mechanisms. Selected publications include:

  • "Antiallergic drug desloratadine as a selective antagonist of 5HT2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction," 2020, Aging Cell
  • "Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2," 2021, Biomaterials
  • "Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease," 2021, Cellular and Molecular Gastroenterology and Hepatology
  • "Magnolol effectively ameliorates diabetic peripheral neuropathy in mice," 2022, Phytomedicine
  • "Free-Radical-Promoted Dehydrogenative Coupling of Polyfluorinated Alcohol with Quinone, Chromone, and Coumarin," 2020, Organic Letters

Xu Shen has frequently collaborated with several coauthors, contributing to a consistent scientific output. The most frequent collaborators include:

  • Jiaying Wang
  • Jian Lu
  • Minyi Qian
  • Jianlu Lv
  • Yin Lu

Best Publications

  • Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features

    Lili Chen;Jian Li;Cheng Luo;Hong Liu

  • Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro

    Lili Chen;Chunshan Gui;Xiaomin Luo;Qingang Yang

  • d-Alanine:d-alanine ligase as a new target for the flavonoids quercetin and apigenin

    Dalei Wu;Yunhua Kong;Cong Han;Jing Chen

  • Arctigenin Effectively Ameliorates Memory Impairment in Alzheimer's Disease Model Mice Targeting Both β-Amyloid Production and Clearance

    Zhiyuan Zhu;Jianming Yan;Wei Jiang;Xin-gang Yao

  • pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.

    Jinzhi Tan;Koen H.G. Verschueren;Kanchan Anand;Jianhua Shen

  • In Silico Prediction of Chemical Acute Oral Toxicity Using Multi-Classification Methods

    Xiao Li;Lei Chen;Feixiong Cheng;Zengrui Wu

  • Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

    Jianhua Shen;Xiaoying Xu;Feng Cheng;Hong Liu

  • Three flavonoids targeting the beta-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: crystal structure characterization with enzymatic inhibition assay.

    Liang Zhang;Yunhua Kong;Dalei Wu;Haitao Zhang

  • Association between cigarette smoking and Parkinson’s disease: A meta-analysis

    Xiao Li;Xiao Li;Weihua Li;Guixia Liu;Xu Shen

  • Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion.

    Xiao-Ling Yu;Tiancen Hu;Jia-Mu Du;Jian-Ping Ding

  • Structural and Functional Characterization of Falcipain-2, a Hemoglobinase from the Malarial Parasite Plasmodium falciparum.

    Tanis Hogg;Krishna Nagarajan;Saskia Herzberg;Lili Chen

  • Nucleocapsid Protein of SARS Coronavirus Tightly Binds to Human Cyclophilin A

    Cheng Luo;Haibin Luo;Suxin Zheng;Chunshan Gui

  • The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1

    Haibin Luo;Qing Chen;Jing Chen;Kaixian Chen

  • Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections

    Zhiqiang Qin;Jian Zhang;Bin Xu;Lili Chen

  • Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.

    Shuai Chen;Lili Chen;Jinzhi Tan;Jing Chen

  • Identification of an epitope of SARS-coronavirus nucleocapsid protein

    Ying Lin;Xu Shen;Rui Fu Yang;Yi Xue Li

  • Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin

    Yun-Guang Tong;Xiong-Wen Zhang;Mei-Yu Geng;Jian-Ming Yue

  • Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation

    Jianhua Cai;Cong Han;Tiancen Hu;Jian Zhang

  • A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.

    Bin Xiong;Chun Shan Gui;Xiao Ying Xu;Cheng Luo

  • Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.

    Shuaishuai Ni;Yaxia Yuan;Jin Huang;Xiaona Mao

Frequent Co-Authors

Hualiang Jiang
Hualiang Jiang Chinese Academy of Sciences
Lihong Hu
Lihong Hu Chinese Academy of Sciences
Kaixian Chen
Kaixian Chen Chinese Academy of Sciences
Xiaomin Luo
Xiaomin Luo Chinese Academy of Sciences
Hong Liu
Hong Liu Shandong University
Yue-Wei Guo
Yue-Wei Guo Chinese Academy of Sciences
Yun Tang
Yun Tang East China University of Science and Technology
Cheng Luo
Cheng Luo Chinese Academy of Sciences
Jianping Ding
Jianping Ding Chinese Academy of Sciences
Weiliang Zhu
Weiliang Zhu Chinese Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Xu Shen

Trending Scientists

Recently Published Articles